December 15th, 2022

NCBiotech Awards inSoma $500K Strategic Growth Funding

The North Carolina Biotechnology Center (NCBiotech) has awarded inSoma $500,000 strategic growth funding to advance InSoma’s Fractomer™️ product through early commercialization, including the scale up of GMP production, the completion of preclinical studies, and the finalization of reimbursement and regulatory strategies for follow-on trials.  This funding builds on the initial $250,000 NCBiotech provided in 2020. NCBiotech funding is an impactful source of support for North Carolina-based bioscience research, technology and entrepreneurship, and inSoma is grateful to be a part of the NCBiotech investment portfolio.

Read whole article
July 19th, 2022

$2M grant awarded from the National Cancer Institute

inSoma is thrilled to announce we have been awarded $2M from the National Cancer Institute to develop our fat grafting scaffold as a safe and natural alternative to silicone implants for patients opting for breast reconstruction.

September 21st, 2021

inSoma Awarded NIH Grant to Develop 3D Cell Culture Platform

inSoma Bio is excited to announced we have been awarded additional support funding from the National Institute of Health (NIH) for the development of a 3D cell culture platform for organoids and stem cells. This new technology will be validated by the University of Chapel Hill for its unique ability to grow and release sensitive cell types from culture without the need for harmful enzymes.

Read whole article